This past weekend’s edition on DexCom was just out in front of a quick burst to a new all time high. I continue to believe that the widely expected pending FDA Approval on their blood glucose monitoring device will create a much bigger spike in the stock.
As I pointed out in the weekend edition, the stock is hard to buy because there really aren’t any retracements of any note. Apparently, there is big demand and little supply.
As you can see from the chart, this stock is hard to buy. My advice was to take a partial position or no position until there was a pullback.
If you took a parital position, you have to be happy today. My guess is the stock will now flucuate between $17 and $19. As it bases, you will have another shot. This move leads me to believe the upside target with the FDA Approval will be more like $25.
Comments and questions are welcome.
What is the hold up with HYD? or Any comments on any possible news about the permits or anything else? We have heard nothing even on this amazing run up on the stock! Thanks
Editor: I’m not sure what you mean by hold up. What are you expecting. According to the news, the President is in Guinea trying to finalize getting the first drilling permits. The market is pricing in the event already. I don’t know when or if they will announce they have obtained the permits, but I hope it is soon as well. Perhaps in the next week, but I have no way of knowing. If it is a concern, take your profit.